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With impending rollout of new conjugate typhoid vaccines, better estimates of typhoid case-fatality ratio are needed for countries 
to set priorities for public health programs. We enrolled 1425 patients of all ages with blood culture–confirmed Salmonella Typhi 
from laboratory networks serving inpatients and outpatients in Dhaka, Bangladesh. Participants were asked about symptoms and 
complications including death experienced over a median 3-month period following blood culture diagnosis. Four fatal cases were 
identified (case-fatality ratio of 0.3% [95% confidence interval, .05%–.55%]). Applying this case-fatality ratio to global typhoid bur-
den estimates would reduce deaths by 70%.
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Typhoid fever is a systemic infection caused by Salmonella 
enterica serovar Typhi that can lead to severe outcomes 
including death [1]. The case-fatality ratio (the proportion of 
people infected with S. Typhi who die as a result of infection) 
remains poorly characterized [2]. Few studies address case-fa-
tality ratio, and they provide wide-ranging estimates that vary 
depending on study methodology [2–4]. An accurate case-fa-
tality ratio is important as it contributes proportionally to dis-
ease burden estimates and thus to cost-effectiveness analyses, 
making it crucial for policy, public health, and resource allo-
cation decisions.
In 2004 and 2008, Crump et  al reviewed available literature 
to estimate the global burden of typhoid and noted a dearth of 
data to estimate case-fatality ratio. Available data had wide rang-
ing results depending on if they were derived from community 
or hospital-based studies [5]. Community-based studies had a 
median case-fatality ratio of 0% (range, 0–1.8%), while hospi-
tal-based studies that included patients of all ages had a higher 
median case-fatality ratio of 3.1% (range, 0–13.9%) [6]. Similarly, 
a 2015 review found an overall hospital-based case-fatality ratio 
of 2% compared to 0% in community-based studies [7]. Based on 
available data and the opinion that typhoid cases mainly occur in 
the community rather than in the hospital, Crump et al settled on 
a 1% case-fatality ratio that has since been widely cited [5].
Differences in results from community- vs hospital-based 
studies highlight the difficulty in establishing an accurate 
case-fatality ratio when focusing on either population alone. 
Each captures a subset of patients and they likely represent 
upper and lower limits rather than a representative ratio. To 
capture the experiences of both populations, we estimated 
case-fatality ratio from laboratory networks utilized by outpa-
tients and by hospitalized inpatients.
METHODS
Between January and December 2010, we recruited patients 
with S. Typhi diagnosed by blood culture, identified from 6 
large, private laboratory networks serving Dhaka, Bangladesh. 
Laboratory networks were selected based on high volume 
(200–300 blood cultures per month), presence of a supervising 
microbiologist, and service to hospitals as well as outpatient 
pharmacies and clinics. Laboratories performed blood cultures 
on patients irrespective of formal referral from a doctor.
Each laboratory kept a log of all patients obtaining blood 
cultures during the study period. Study personnel visited lab-
oratories weekly, obtaining contact information and antibiotic 
resistance testing results for patients with blood cultures pos-
itive for S. Typhi who gave permission to be contacted. Study 
personnel then called eligible participants to explain the study, 
obtain informed consent, and administer a questionnaire. 
Follow-up information was obtained through a second and 
third phone interview, attempted at 2-week intervals after the 
initial questionnaire. For enrollment and follow-up, study per-
sonnel tried a minimum of 9 times to reach patients or their 
relatives.
Inclusion criteria were a blood culture–positive for S. Typhi 
at a study laboratory and residence within Dhaka city, with no 
age restrictions. The head of household was interviewed for 
adults too sick to respond and for children <18 years of age.
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Data from the Bangladesh Bureau of Statistics were used for 
demographic comparisons [8]. Two laboratory networks used 
international guidelines for antimicrobial susceptibility test-
ing (Clinical Laboratory and Standards Institute and European 
Committee on Antimicrobial Susceptibility Testing); the other 
4 used internal guidelines.
The study protocol was approved by the International Centre 
for Diarrhoeal Disease Research, Bangladesh (icddr,b) ethical 
review committee.
Statistical Analyses
Assuming a 1% typhoid fever case-fatality ratio [5], a 0.5% mar-
gin of error, and a 95% confidence interval (CI), we aimed to 
enroll 1521 patients with typhoid.
All enrolled participants were included in the final analy-
ses. Simple descriptive statistics were performed to compare 
frequencies and proportions. Bivariate analyses were done 
using the χ2 test with statistical significance set at P  <  .05. 
Sensitivity analysis was done to assess the impact that deaths 
among participants lost to follow-up would have on case-fa-
tality ratio.
RESULTS
A total of 1425 patients were enrolled, all of whom answered 
an initial interview a median of 6.6 (interquartile range [IQR], 
4.7–8.3) weeks after blood cultures were drawn. Data on the 
number of eligible participants not enrolled, either because 
they were unable to be contacted or declined participation, were 
not available. At the second interview (median, 8.9 [IQR, 7.1–
10.7] weeks after culture), 44 (3.1%) participants were lost to 
follow-up; at the third and final interview (median, 11.4 [IQR, 
9.4–13.4] weeks after culture), an additional 32 (2.2%) were lost. 
Participants were mostly male (59%) and had a median age of 
14 years (range, 6 months–64 years). Compared to the general 
urban Dhaka population, the study cohort had more resources 
(5% vs 57% owning a computer, 40% vs 86% owning a refriger-
ator), had fathers with higher levels of education (26% vs 72% 
with high school or higher level of schooling), and had more 
access to piped water (58% vs 90%) and a flush toilet (59% vs 
74%) [8] (Table 1). Patients lost to follow-up were less likely to 
drink boiled water (81% vs 90%; P = .01) and more likely to use 
a toilet with a septic tank (33% vs 19%; P = .01).
We identified 4 fatal cases (0.3% [95% CI, .05%–.55%). All 
were adult females and were hospitalized for typhoid fever; 3 
died in the hospital, 1 died immediately after leaving the hos-
pital, and all died within 3  days of blood culture collection. 
Among hospitalized patients, the case-fatality ratio was 1.1% 
(95% CI, 0.02%–2.1%) and 0% in outpatients. Compared to sur-
vivors, patients who died had fewer resources and had fathers 
with less education (Table 1). Sensitivity analysis for a scenario 
assuming that all participants lost to follow-up did so because of 
death increases the case-fatality ratio to 5.6%.
Among all participants, the most common symptoms expe-
rienced were fever, vomiting, and abdominal pain. Potentially 
more severe symptoms, including blood in stool or seizures, 
were reported in <5%. No intestinal perforations were reported 
(Table 1).
Antibiotic Resistance
Testing for all 3 historical first-line drugs for typhoid (ampi-
cillin, chloramphenicol, and cotrimoxazole) was done in 661 
(53%) isolates. Of those tested, 175 (26%) were resistant to 
all 3. Azithromycin resistance was reported in 38% of isolates 
tested (Tables 2 and 3).
DISCUSSION
We found an overall case-fatality ratio of 0.3% (95% CI, .05%–
.55%) for patients with blood culture–confirmed Salmonella 
Typhi, identified through 6 laboratory networks serving inpa-
tients and outpatients in Dhaka, Bangladesh. This is considera-
bly lower than the 1% estimated by Crump et al. While the 1% 
estimate tried to balance findings from studies focused on either 
community or hospital patients alone, our study attempted to 
directly capture both populations at the same time. Using a 
broader surveillance method, this study adds an important data 
point on typhoid case-fatality ratio for an endemic region.
Community-based studies often take an active, popula-
tion-based approach, where a community is repeatedly sur-
veyed for typhoid. These studies directly measure incidence by 
trying to capture all cases, including mild ones that otherwise 
would not present to the healthcare system. The intensity and 
expense of these studies make them uncommon and geograph-
ically limited [7, 9]. They also interrupt the natural history of 
disease because earlier diagnosis leads to earlier treatment, pre-
venting more severe sequelae and artificially lowering case-fa-
tality ratios [9, 10].
In contrast, hospital-based estimates are logistically simpler 
but biased toward patients with more severe symptoms requir-
ing hospital-level care and those with the resources to access 
such care [9, 10]. They risk missing milder cases that stay in the 
community and patients who cannot access care or otherwise 
seek care in the informal sector [9, 11]. By underestimating the 
total number of cases in the population, they result in artificially 
high case-fatality estimates.
The limitations of each approach should be taken into con-
sideration when designing research studies or planning public 
health policy. Community-based studies underestimate case 
fatalities and thus would provide limited evidence on lives saved 
through vaccination. Hospital-based estimates of case fatalities 
or disease severity, by contrast, are difficult to extrapolate to the 
broader community.
By utilizing a laboratory network serving both the commu-
nity and hospitals and thus expanding the population repre-
sented without altering the natural course of disease, our study 
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attempts to improve estimates for both the numerator (total 
number of fatal cases) and the denominator (total number of 
typhoid cases) used to calculate case-fatality ratio. Applying our 
ratio of 0.3% (95% CI, .05%–.55%) to the 2012 estimate of 26.9 
million global cases of typhoid suggests 80 700 (95% CI, 13 450–
147 950) annual deaths, much lower than the 269 000 deaths 
estimated using the 1% case-fatality ratio by Crump et  al, or 
the half a million deaths using the 2% case-fatality ratio found 
by Azmatullah et  al [3, 5, 7]. These numbers have important 
implications for national and global decision making, from the 
allocation of limited public health dollars to vaccine implemen-
tation and healthcare infrastructure development.
Table 1. Demographics of Enrolled Patient Population and Symptoms Experienced by Hospitalized and Nonhospitalized Patients
Characteristic All (N = 1425)
Hospitalized  
(n = 370 [26%])
Not Hospitalized 
(n = 1051 [74%]) P Value Died (n = 4 [0.3%])
Demographic characteristics
 Sex
  Male 839 (59) 212 (57) 627 (60) .43 0 (0)
  Female 586 (41) 158 (43) 424 (40) 4 (100)
 Age, y
  Age, y, median (IQR) 14 (5–23) 13 (2–21) 14 (6–23) .91 Ages: 32, 39, 43, 65
  No. <5 y old (% of population) 304 (21) 97 (26) 207 (20) .37 0 (0)
  Range 0.6–64 0.75–60 0.6–64
Household characteristics
 Education level of father .46
 No school 47 (3.3) 15 (4) 31 (3) 1 (25)
 Less than high school 329 (23) 77 (21) 250 (24) 2 (50)
 High school graduate 196 (14) 49 (13) 147 (14) 0 (0)
 College or above 828 (58) 220 (60) 607 (58) 1 (25)
 Other 25 (2) 9 (2) 16 (2)
 Own a motor car 245 (17) 67 (18) 178 (17) .81 1 (25)
 Computer/laptop in house 811 (57) 209 (56) 602 (57) .95 1 (25)
 Refrigerator in house 1219 (86) 319 (86) 900 (86) .82 4 (100)
 Water source
 City water supply 1284 (90) 334 (90) 950 (90) .88 3 (75)
 Tube well 14 (1) 5 (1) 9 (1) .62 1 (25)
 Drink boiled water 1266 (89) 328 (89) 938 (89) .86 2 (50)
 Use gas for cooking 1255 (88) 336 (91) 919 (87) .17 3 (75)
 Own home or land in Dhaka 589 (41) 164 (44) 425 (40) .09 1 (25)
 Main toilet is a flush toilet 1061 (74) 291 (79) 770 (73) .18 2 (50)
Symptoms experienced by patient
 Fever 1389 (97) 368 (99) 1017 (97) .004
 Vomiting 601 (44) 188 (53) 413 (40) <.001
 Blood in stool 31 (2) 10 (3) 21 (2) .59
 Abdominal pain 291 (21) 102 (28) 189 (18) <.001
 Abdominal distension 57 (4) 28 (8) 29 (3) <.001
 Fainted 46 (3) 20 (6) 26 (3) .02
 Had convulsion or seizure 45 (3) 22 (6) 23 (2) .001
 Hypothermia of hand or foot 181 (13) 70 (20) 111 (11) <.001
 Psychological stress 38 (3) 20 (6) 18 (2) <.001
Data are presented as No. (%) unless otherwise indicated.
Abbreviation: IQR, interquartile range.
Table 2. Antibiotic Usage Among Patients
Antibiotic Usage All (N = 1425) Hospitalized (n = 370) Not Hospitalized (n = 1051) P Value Died (n = 4)
Started antibiotics
 Before blood culture 665 (47) 199 (54) 463 (44) .05 3 (75)
 After blood culture but before results 
reported
238 (17) 70 (19) 167 (16) .45 1 (25)
 After blood culture and resistance report 515 (36) 100 (27) 415 (40) <.001 0
 Unknown 2 (0.1) 0 2 (0.2) … 0
Data are presented as No. (%).
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Children in our study bore a disproportionate burden of 
typhoid disease. Children <5 and <15 years old accounted for 
21% and 51% of all cases, even though they account for 10% 
and 30% of the urban Bangladeshi population, respectively [8]. 
This is similar to age-trends reported in the literature, though 
less than what was found in a study of Dhaka slums where 60% 
of typhoid cases were in children <5  years old [12]. Despite 
this higher case burden, we found no fatal cases among chil-
dren, consistent with systematic reviews that have found lower 
case-fatality ratios in children compared to adults [6, 7].
Our data also suggest that those who die from typhoid are 
poorer than those who survive, and that those able to obtain 
cultures have more resources than the general population. 
Socioeconomic status has been found to be the most import-
ant determinant in healthcare-seeking behavior in Bangladesh 
[13]. Patients lacking resources are the least likely to seek care, 
have blood cultures collected, or be treated in hospitals, and are 
the most likely to suffer severe outcomes including death. By 
incompletely capturing this population, we are both underrep-
resenting the total number of typhoid cases as well as the total 
number of fatal cases in the population. The exact ratio of these 
missed cases is unclear and could lower or raise the true popu-
lation case-fatality ratio.
An important limitation in our study is that fatal cases of 
typhoid are at risk of not having been enrolled in the first place. 
To address this limitation, we made multiple attempts to con-
tact family members of eligible participants if they could not be 
directly reached. All 4 fatal cases in our study died before initial 
contact but were able to be identified this way. Despite this, it is 
possible that fatal cases were missed at enrollment. Data on how 
many eligible patients were not enrolled was not consistently 
maintained at the different laboratories, preventing sensitivity 
analysis.
A participant who dies during the study would similarly be 
at risk of being lost to follow-up, regardless of attempts at fam-
ily contact. While most (95%) completed a median 3 months 
of follow-up, 76 people were lost before the end of the study. 
However, since initial enrollment was a median of 6.6 weeks 
after blood culture, we had more than a month of data for the 
majority enrolled. This time period includes the acute typhoid 
fever period when the majority of deaths in the cohort would 
have been expected to occur [14]. Consistent with this was that 
all 4 fatal cases in our study died prior to enrollment, only 3 days 
from time of blood culture. Still, even a small number of missed 
deaths would have a large impact on the calculated case-fatality 
ratio, and sensitivity analysis show that case-fatality ratio could 
range from 0.3% to 5.6%.
While we found high azithromycin resistance, the heteroge-
neity of laboratory techniques used limit our ability to interpret 
this data.
Case-fatality ratio likely varies regionally and is influenced 
by healthcare access, resources and infrastructure, antimicro-
bial resistance patterns, and socioeconomics. Studies to assess 
case fatality in other countries and settings could help inform 
regional and global typhoid burden estimates [6, 9]. Attention 
should be focused on outpatients (where typhoid disease is 
concentrated) and on people with lower socioeconomic status 
or that seek care in the informal sector (where patients are at 
higher risk for poor outcomes) [12, 13]. Our 0.3% case-fatality 
ratio utilizes a laboratory-based network serving both outpa-
tients and inpatients but misses those not accessing the formal 
health sector. It provides an additional point estimate of this 
important parameter, and offers a cost-effective method to rep-
licate. With the potential for both vaccines and antimicrobial 
resistance to alter typhoid morbidity and mortality, an accurate 
and continually updated understanding of case-fatality ratio is 
important to update global burden estimates and for national 
and global policy making [15].
Notes
Acknowledgments. The authors gratefully acknowledge the data collec-
tors involved with this study and the authorities at the diagnostic centers for 
their collaboration. The authors also gratefully acknowledge John Crump 
and Eric Mintz for their thoughtful review during protocol development. 
icddr,b acknowledges with gratitude the commitment of the Centers for 
Disease Control and Prevention (CDC) to its research efforts, as well as the 
governments of Bangladesh, Canada, Sweden, and the United Kingdom for 
providing core/unrestricted support to icddr,b.
Financial support. This research protocol was funded by the CDC 
(grant number 081126).
Supplement sponsorship. This article is part of the supplement 
“Surveillance for Enteric Fever in Asia Project (SEAP),” sponsored by the 
Sabin Vaccine Institute.
Table 3. Antimicrobial Susceptibility Testing of Salmonella Typhi Blood Culture Isolates Performed at 6 Dhaka, Bangladesh–Based Laboratories
Antibiotic
Antibiotic Resistance, No. (% of Tested Isolates)
No. of Isolates Tested Sensitive Intermediate Resistant
Ampicillin 872 499 (57) 3 (0) 370 (42)
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Cefixime 1250 1168 (93) 71 (6) 11 (1)
Ceftriaxone 1254 1253 (>99) … 1 (0)
Chloramphenicol 870 677 (78) … 193 (22)
Ciprofloxacin 1239 966 (73) 175 (14) 98 (8)
Cotrimoxazole 1238 902 (73) … 336 (27)
Nalidixic acid 1193 25 (2) 2 (0) 1166 (98)
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